Surrey Heartlands

Joint Formulary & PAD

Budesonide with formoterol (DuoResp Spiromax) - Asthma

You are here : Home > Formulary Search > Budesonide with formoterol (DuoResp Spiromax) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important

DuoResp Spiromax 160/4.5 - licensed for AIR and MART from 12 years of age.

Second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Prescribe by BRAND.

 

Status 2

Blue
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
R
Restrictions / Comments :
Important

DuoResp Spiromax 320/9 - higher dose ICS/LABA for specialist recommendation only.

Prescribe by BRAND.

Documentation

Webpage
How to use a Spiromax inhaler - Patient information leaflet
Webpage
How to use a Spiromax inhaler - video
Webpage
NICE NG80 - Asthma-diagnosis-monitoring-and-chronic-asthma-management
Patient resource
MART Duoresp Asthma Action plan - July 2019

PAD Profile

ChemicalSubstance :
Budesonide with formoterol (DuoResp Spiromax)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics, MART action plans, maintenance and reliever therapy
Brand Names Include :
DuoResp Spiromax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Asthma
Supporting Documents :
4
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Budesonide with formoterol (DuoResp Spiromax) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (0)

  • No records returned.